KABUTO KOWA

Serial Number 79380332
Registration 7592546
700

Registration Progress

Application Filed
Aug 14, 2023
Under Examination
Approved for Publication
Oct 8, 2024
Published for Opposition
Oct 8, 2024
Registered
Dec 10, 2024

Trademark Image

KABUTO KOWA

Basic Information

Serial Number
79380332
Registration Number
7592546
Filing Date
August 14, 2023
Registration Date
December 10, 2024
Published for Opposition
October 8, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 10, 2024
Registration
Registered
Classes
005 030 032

Rights Holder

KOWA COMPANY, LTD.

03
Address
6-29, Nishiki 3-chome,
Naka-ku, Nagoya-shi Aichi-ken 460-8625
JP

Ownership History

KOWA COMPANY, LTD.

Original Applicant
03
JP

KOWA COMPANY, LTD.

Owner at Publication
03
JP

KOWA COMPANY, LTD.

Original Registrant
03
JP

Legal Representation

Attorney
Erica Halstead

USPTO Deadlines

Next Deadline
1979 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-10)
Due Date
December 10, 2030
Grace Period Ends
June 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description
May 31, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
May 14, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB
May 14, 2025 FIMP P FINAL DISPOSITION PROCESSED
Mar 22, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 10, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 4, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 4, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 10, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 8, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2024 PUBO A PUBLISHED FOR OPPOSITION
Sep 18, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Aug 30, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED
Aug 30, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 27, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 27, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2024 CNRT R NON-FINAL ACTION WRITTEN
Aug 1, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2024 GNRT F NON-FINAL ACTION E-MAILED
May 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 24, 2024 RFNT P REFUSAL PROCESSED BY IB
Mar 28, 2024 RFRR P REFUSAL PROCESSED BY MPU
Mar 28, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 8, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2024 CNRT R NON-FINAL ACTION WRITTEN
Mar 1, 2024 DOCK D ASSIGNED TO EXAMINER
Oct 21, 2023 MAFR O APPLICATION FILING RECEIPT MAILED
Oct 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2023 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 5, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, anti-inflammatory agents, analgesics, vitamin preparations, pharmaceutical tonics for the relief of muscular pain, shoulder stiffness, lumbar pain, eyestrain and fatigue for medical purposes, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, pharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; nutritional additives for medical purposes in the nature of dietary supplements for humans or animals; medicinal tonics for the relief of muscular pain, shoulder stiffness, lumbar pain, eyestrain and fatigue; dietary supplement for human use; hand-sanitizing preparations; disinfectants for sanitary purposes; antimicrobials for dermatologic use; vermin destroying preparations, fungicides, herbicides, insect-repellents; adhesive plasters for medical purposes, namely, for dressing wounds; crude drugs, namely, medicines made of rootstock, bark, leaves, fruits, seeds, rhinoceros' horn, musk or bear's gall, used for the treatment of pain, cold, fever, anemia, and for use as diuretics or astringents; absorbent cotton for medical purposes; adhesive plasters for sanitary purposes; bandages for dressings
Class 030
Tea; coffee; coffee-based beverages; cocoa; cocoa-based beverages; chocolate confectionery; chocolate; ice cream for desserts; ice cream; western-style confectionery, namely, frozen confectionery; baked confectionery made of sugar; cakes; rice-based snack food; snacks, namely, granola snacks; flour-based snack foods; starch-based candies (ame); pellet-shaped rice crackers (arare); rice crackers; rice dumplings; bean-jam filled wafers (monaka); dried sugared cakes of rice flour (rakugan); ice candies; caramels; candies; cookies; chewing gum; doughnuts; candy containing dried fruit being confectionery; biscuits; fruit jelly candy; bread and buns; sandwiches; steamed buns stuffed with minced meat (niku-manjuh); hamburger sandwiches; pizzas; hot dog sandwiches; meat pies
Class 032
Carbonated drinks, non-alcoholic; soft drinks; energy drinks, non-alcoholic; energy drinks; fruit juices; vegetable juices being beverages

Additional Information

Translation
The English translation of KABUTO in the mark is HELMET.

Classification

International Classes
005 030 032